UnitedHealth (UNH) Shares Decline Following Berkshire Hathaway Exit, Reuters Reports
Quick Take
UnitedHealth shares fell after Berkshire Hathaway sold its stake, according to Reuters.
Key Points
- Berkshire Hathaway exits UnitedHealth investment.
- Stock prices declined significantly post-announcement.
- Market reacts to major shareholder changes.
📖 Reader Mode
~2 min readVardah Gill
2 min read
UnitedHealth Group Incorporated (NYSE:UNH) is included among the 10 Best “Dogs of the Dow” Stocks to Buy for the Rest of 2026.
On May 18, Reuters reported that shares of UnitedHealth Group Incorporated (NYSE:UNH) dropped more than 2% on Monday after Berkshire Hathaway revealed it had sold its stake in the healthcare giant as part of a first-quarter portfolio reshuffle led by CEO Greg Abel.
Berkshire’s investment in UnitedHealth had attracted attention last August when the company disclosed it bought 5 million shares. At the time, the move boosted investor confidence, with many viewing it as a vote of confidence in the company’s turnaround efforts under CEO Stephen Hemsley. That position is now gone. On May 15, Berkshire confirmed it had exited its investment in the health insurer.
Separately, on May 13, Bank of America analyst Kevin Fischbeck raised the firm’s price recommendation on UNH to $420 from $380. It reiterated a Neutral rating on the shares. The analyst said conversations with the company’s leadership team at the BofA Healthcare Conference carried a “bullish” tone. Management indicated that it believes the company can return to at least the low end of its target margins across most of its businesses by 2028.
UnitedHealth Group Incorporated (NYSE:UNH) operates across several healthcare and wellness businesses, including Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare. Its insurance operations span employer and individual plans, Medicare and retirement services, and community and state programs.
While we acknowledge the potential of UNH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 12 Best Micro-Cap Dividend Stocks To Buy Now and 11 Best Rising Dividend Stocks to Buy Right Now
Disclosure: None. Follow Insider Monkey on Google News.
— Originally published at finance.yahoo.com
More from Yahoo Finance
See more →These Super Stocks Could Be the Biggest Winners in the AI Inference and Agentic AI Economy
The article highlights top stocks poised for growth in the AI inference and agentic AI sectors.